Results 161 to 170 of about 652,471 (299)
DEAD-box ATPase-marked condensates coordinate compartmentalized translation and antibiotic persistence. [PDF]
Zhang Z, Li D, Zheng B, Liu JF.
europepmc +1 more source
Hepatocyte‐derived extracellular vesicles deliver miR‐328‐3p to trigger PP2A‐B56δ–mediated p‐NLRP3S295‐dependent metaflammation in macrophages upon microcystin‐LR exposure. 2‐DG, 2‐deoxy‐D‐glucose. B56δ, protein phosphatase 2A‐B56δ. ER, endoplasmic reticulum. iHD‐EV, inducible hepatocyte‐derived extracellular vesicles. IP3R, inositol 1,4,5‐triphosphate
Jia‐Shen Wu +13 more
wiley +1 more source
Vitamin D (VitD) modulates olfactory function by remodeling dendrodendritic synapses in tufted cells through vitamin D receptor‐dependent transcriptional and translational mechanisms. VitD regulates synaptic protein translation partially via mTOR signaling.
Pengcheng Ren +9 more
wiley +1 more source
Recent progress in serine metabolism reprogramming in tumors and strategies for serine deprivation. [PDF]
Liu H, Liu Y.
europepmc +1 more source
AMPA receptor mediated
Steve J. Sullivan, Robert F. Miller
openalex +2 more sources
PDAC has a poor prognosis due to chemoresistance. We revealed that MCU upregulation is associated with chemoresistance and stemness in PDAC. MCU‐mediated Ca2+ influx induced ER stress, activating the PERK‐ATF4/NRF2 axis to enhance PSAT1/SLC711 expression and glutathione synthesis, reducing ROS and maintaining stemness.
Zekun Li +17 more
wiley +1 more source
Amino acid metabolism of the thermophilic acetogen Thermacetogenium phaeum. [PDF]
Cai Y +3 more
europepmc +1 more source
Oxidative phosphorylation (OXPHOS) activity serves as a critical metabolic determinant of radiotherapy outcomes in esophageal squamous cell carcinoma (ESCC). The CEBPB/AREG/EREG axis drives radioresistance in ESCC by reprogramming OXPHOS. AREG and EREG function as predictive biomarkers for nCRT response and prognosis of ESCC patients.
Zhang Lin +15 more
wiley +1 more source
Strategic risk assessment in oncology: Utilizing single-agent activity to boost combination therapy approvals. [PDF]
Kasim A +11 more
europepmc +1 more source

